The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiscoverIE Regulatory News (DSCV)

Share Price Information for DiscoverIE (DSCV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 728.00
Bid: 595.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 142.00 (23.866%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 728.00
DSCV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Exercise of share options

6 Jun 2018 09:00

RNS Number : 4671Q
discoverIE Group plc
06 June 2018
 

06 June 2018

 

discoverIE Group plc

 

EXERCISE OF SHARE OPTIONS

 

discoverIE Group plc (LSE:DSCV, the "Company") announces that application has been made to the UK Listing Authority and the London Stock Exchange for a listing and admission of 1,898,921 ordinary shares of 5 pence each in the Company ("Shares"). These new Shares are being issued and allotted pursuant to the exercise of options under the Company's 2008 Long Term Incentive Plan and will rank equally with the existing issued ordinary shares.

 

In respect of the Company's 2008 Long Term Incentive Plan options being exercised, the Company has been notified that Mr Nick Jefferies, Group Chief Executive, and Mr Simon Gibbins, Group Finance Director, have exercised in full their options over Shares which vested in connection with awards granted on 31 March 2010, 20 July 2010, 28 March 2012 and 28 March 2013. These nil cost options relate to the three year performance periods ended 31 March 2013, 20 July 2013, 28 March 2015 and 28 March 2016. Further details relating to the performance conditions of the awards are set out in the Annual Report and Accounts 2013, 2015 and 2016 which were mailed to shareholders on 20 June 2013, 26 June 2015 and 17 June 2016.

 

The table below shows the number of options exercised and shares to be issued to Nick Jefferies and Simon Gibbins. In addition, a total of 637,140 options have been exercised by other employees of the Company pursuant to vested awards at the same dates.

 

 

Number of nil-cost options exercised

Vesting Date

31 March 2010

20 July

2010

28 March 2012

28 March 2013

Total

Nick Jefferies

340,105

 -

264,593

233,696

838,394

Simon Gibbins

-

192,431

122,638

108,318

423,387

 

Following Admission, Nick Jefferies will hold a total of 1,343,166 Shares and Simon Gibbins will hold a total of 456,662 Shares.

 

Following Admission, which is expected to take place on 11 June 2018, the total number of Shares in issue and voting rights in the Company will be 73,316,777 Shares. There are no Shares held in treasury.

 

The above figure (73,316,777) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

For further information please contact:

 

 

discoverIE Group plc

 

Joanna Harkus Madge: Group Company Secretary 01483 544500

 

Notes to Editors:

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Nick Jefferies

2

Reason for the notification

a)

Position / status

Group Chief Executive

b)

Initial notification / amendment

Initial notification

3

Details of issuer

a)

Name

discoverIE Group plc

b)

LEI

213800BMDLQU1VEEAN68

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares in discoverIE Group plc

 

 

GB0000055888

b)

Nature of the transaction

Exercise of nil cost options made pursuant to the Company's 2008 Long Term Incentive Plan

c)

Price(s) and volume(s)

 

Price

Volume

0 pence per share

838,394

 

 

d)

Aggregated information

 

Price

Volume

Total

0 pence per share

838,394

£0

e)

Date of the transaction

5 June 2018

f)

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Simon Gibbins

2

Reason for the notification

a)

Position / status

Group Finance Director

b)

Initial notification / amendment

Initial notification

3

Details of issuer

a)

Name

discoverIE Group plc

b)

LEI

213800BMDLQU1VEEAN68

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares in discoverIE Group plc

 

 

GB0000055888

b)

Nature of the transaction

Exercise of nil cost options made pursuant to the Company's 2008 Long Term Incentive Plan

c)

Price(s) and volume(s)

 

Price

Volume

0 pence per share

423,387

 

 

d)

Aggregated information

 

Price

Volume

Total

0 pence per share

423,387

£0

e)

Date of the transaction

5 June 2018

f)

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHDQLBBVQFZBBV
Date   Source Headline
18th Apr 20247:00 amRNSFull Year Trading Update
28th Mar 20247:30 amRNSDirector Declaration
22nd Mar 20248:09 amRNSNotification of Major Holdings
20th Mar 20243:45 pmRNSDirector/PDMR Shareholding
14th Mar 20241:21 pmRNSDirector/PDMR Shareholding
19th Feb 20244:07 pmRNSDirector/PDMR Shareholding
6th Feb 20247:00 amRNSTrading Update
29th Jan 202410:31 amRNSDirector / PDMR Shareholding
8th Jan 20248:41 amRNSNotification of Major Holdings
4th Jan 20244:03 pmRNSNotification of Major Holdings
21st Dec 20233:57 pmRNSNotification of Major Holdings
13th Dec 20239:03 amRNSNotification of Major Holdings
8th Dec 202310:52 amRNSNotification of Major Holdings
5th Dec 20237:00 amRNSInterim Results
22nd Nov 20238:30 amRNSNotice of Interim Results
11th Oct 20237:00 amRNSFirst Half Trading Update
15th Sep 20239:11 amRNSDirector/PDMR Shareholding
13th Sep 20237:00 amRNSAcquisition of 2J Antennas Group
5th Sep 20232:17 pmRNSNotification of Major Holdings
31st Aug 20237:00 amRNSAcquisition completion - Silvertel
1st Aug 20237:00 amRNSAcquisition of Silvertel
24th Jul 20232:31 pmRNSResults of Annual General Meeting
24th Jul 20237:00 amRNSTrading Update
27th Jun 202310:53 amRNSDirector / PDMR Shareholding
27th Jun 202310:47 amRNSNotification of Major Holdings
22nd Jun 202312:35 pmRNSAnnual Report & Notice of AGM
19th Jun 20238:35 amRNSNotification of Major Holdings
15th Jun 20239:51 amRNSDirector LTIP Award
7th Jun 20237:00 amRNSPreliminary results
1st Jun 20232:50 pmRNSNotification of Major Holdings
30th May 20237:00 amRNSAppointment of Non-Executive Director
18th May 20231:33 pmRNSNotification of Major Holdings
17th May 202310:25 amRNSNotice of Full Year Results
19th Apr 20237:00 amRNSFull Year Trading Update
18th Apr 20237:00 amRNSNotification of Major Holdings
29th Mar 20235:47 pmRNSNotification of Major Holdings
15th Mar 20233:53 pmRNSNotification of Major Holdings
15th Mar 20238:37 amRNSNotification of Major Holdings
15th Mar 20237:00 amRNSNotification of Major Holdings
23rd Feb 20232:58 pmRNSNotification of Major Holdings
20th Feb 20239:48 amRNSNotification of Major Holdings
15th Feb 20235:33 pmRNSNotification of Major Holdings
13th Feb 202311:36 amRNSNotification of Major Holdings
25th Jan 20237:00 amRNSQ3 Trading Update and Acquisition Completion
6th Jan 20231:41 pmRNSNotification of Major Holdings
6th Jan 20238:24 amRNSNotification of Major Holdings
3rd Jan 202310:38 amRNSNotification of Major Holdings
22nd Dec 20227:00 amRNSAcquisition of Magnasphere Corporation
14th Dec 20224:31 pmEQSParadigm Biopharmaceuticals (PAR): Adapted therapies to meet unmet demand
5th Dec 20229:53 amEQSdiscoverIE Group (DSCV): Focused on sustainable growth

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.